Miebo is available by prescription in the United States [1]. It is a prescription eye drop used to treat the signs and symptoms of dry eye disease [1].
How Does Miebo Work?
Miebo contains perfluorohexyloctane, which is an active ingredient designed to reduce tear evaporation by forming a lipid layer on the ocular surface [1]. This lipid layer helps stabilize the tear film, preventing excessive evaporation and thus alleviating dry eye symptoms [1].
When Was Miebo Approved?
The U.S. Food and Drug Administration (FDA) approved Miebo in May 2023 [1].
What Companies Are Involved with Miebo?
Bausch + Lomb developed Miebo and is responsible for its commercialization [2]. The drug was developed in collaboration with Eleven Biotherapeutics [2].
Are There Any Alternatives to Miebo for Dry Eye Disease?
Yes, there are several alternative treatments for dry eye disease available by prescription and over-the-counter. These include artificial tears, prescription eye drops that reduce inflammation such as cyclosporine (Restasis, Cequa) and lifitegrast (Xiidra), and punctal plugs [3]. The best treatment option depends on the individual's specific condition and its severity [3].
What Are the Potential Side Effects of Miebo?
The most common side effect reported in clinical trials for Miebo was eye irritation [1].
How is Miebo Different from Other Dry Eye Treatments?
Miebo's unique mechanism of action targets tear evaporation by directly addressing the lipid layer of the tear film. Many other dry eye treatments focus on increasing tear production or reducing inflammation [1, 3].
Where Can I Find More Information About Miebo?
More information about Miebo, including its prescribing information, can be found on the Bausch + Lomb website or through healthcare providers. DrugPatentWatch.com provides information on drug patents and exclusivity periods [1, 2].
Sources:
[1] Miebo. Bausch + Lomb. https://www.miebo.com/
[2] Bausch + Lomb Receives FDA Approval for Miebo™ (perfluorohexyloctane) Ophthalmic Solution. Bausch + Lomb. https://www.bausch.com/about-us/news-and-events/news-releases/2023/05/22/miebo-fda-approval/
[3] Dry Eye Disease. National Eye Institute. https://www.nei.nih.gov/learn-about-eyes/eye-conditions-and-diseases/dry-eye-disease